Post hoc analysis of the SONAR trial indicates that the endothelin receptor antagonist atrasentan is associated with less pain in patients with type 2 diabetes and chronic kidney disease
| Autor: | Chan, Kam Wa, Smeijer, J. David, Schechter, Meir, Jongs, Niels, Vart, Priya, Kohan, Donald E., Gansevoort, Ron T., Liew, Adrian, Tang, Sydney C.W., Wanner, Christoph, de Zeeuw, Dick, Heerspink, Hiddo J.L. |
|---|---|
| Zdroj: | In Kidney International December 2023 104(6):1219-1226 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|